AU6253473A - Emulsions - Google Patents
EmulsionsInfo
- Publication number
- AU6253473A AU6253473A AU62534/73A AU6253473A AU6253473A AU 6253473 A AU6253473 A AU 6253473A AU 62534/73 A AU62534/73 A AU 62534/73A AU 6253473 A AU6253473 A AU 6253473A AU 6253473 A AU6253473 A AU 6253473A
- Authority
- AU
- Australia
- Prior art keywords
- sugar
- vitamin
- emulsions
- soluble
- active substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Colloid Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Dairy Products (AREA)
Description
I.15 1114 111116
TEST CHART RESOLUTION MICROCOvY BUREAU NATIONAL -1963 Or STANDARDS
Rel--R~~C-46 SFORM 4 COMMONWEALTH OF AUSTRALIA PATENTS ACT 1952-69 PATENTS ACT 1952-69
We F. Hoffmann-La Roche Co.
of 124-184 Grenzacherstrasse, Basle, Switzerland
hereby apply for the grant of a Patent for an invention entitled r e a Emulsions uo
a o
e o
which is described in the accompanying complete specification. This apolication is a Convention Application and is based on the application numbered 98/73 sc for a patent or similar protection made in Swit z rland o
o
o
on January 5, 1973. c o
o M r address for service is: Our
Care: SPRUSON FERGUSON PATENT ATTORNFYS ESSO eA 'FEB HOUSE, 127 KENT STREET SYDNEY, NEW SOUTH WALES 2000 AUSTRALIA.
Dated this 8th day of November, ,1 1973. F. FMANN-LA RQCHE CO. SKTIENGESELL llAFT
f'o Signature of Applicant To: S an-Jacques Ogay Hans Stiicklin The Commissioner of Patelnts e'bler of procuration Mandatory
RN-~46~1tV FORM 8 r(vJM(~N~Wl~AI TN fl1 Al 1~TR Al IA PATENTS ACT 195 2-69
DECLARATION IN SUPPORT OF A CONVENTION APPLICATION FOR A PATENTOR PATENT OF ADDITION In Support or the Convention Application made for a
pa tent for anivninentitled
"Emualsions,
Full namecand ad- 1, Hans StUcklin dress of Declarant. of 35 Im Hirshaim, Riehen, Switzerland
do solemnly and sincerely declare as follows:-
(or, in the case of an application by a body corporate) 1. 1 am authorised by F.Hoffmann-La Roche Co.Aktiengesellsohaft the ap~plicant for the p~atent tomake this declaration on its behalf. C
Insert country and 2. The basic application as defined by Section 141 of the Act was made in date of basic appli- cation and name of Switzerlaad on the foreign applicant. day of January, 19 73 by
F.Hoffmann-La Roche Co. Aktiengesellschaft -4
(or where a person Other than the ini'entor is the applicant) Full name and ad- dress of Inventor(s) 3. a) Heinrich KJdui b) Gabriel Pongracz of a) 77 Kilchgrundstrasse, Riehen, Switzerland b) 8 RUttihardstrasse, Birsfelden, Switzerland
are k~ the actual inventors of the invention and the facts upon which the applicant is/a~entitled to make the application are as follows:
The company is the assignee of the said inventors.
4. The basic application referred to in paragraph 2 of this Declaration was the first application made in a Convention country in respect of the invention the subject of the applicatioyi. Declared at B" a s ths8th dyft'Oebr19 73.
P I Signture~ of Declarant
The Commissioner of Patents, PUN&FEUSNSYN. SPRUSON FERGUSON, SYDNEY.
COMMONWEALTH OF AUSTRALIA Form PATENTS ACT 1952-69
Class
Application Number 5.)5 ~/3 Lodged. -7 .3 id ?7 -7
.02%i1hpete Specification Lodged 5 i7
Published F7.c7
Ftr4;i*4y eCA1,
R"Ma!,ed Art
:Nop'c of Applicant F.HOFFMANN-IA ROCHE CO. AKI ENGESELLSCHAFT
A' Jress of Applicant 124-184 Grenzachrstrasse, Bas le, Switzerland
aLj'&:lnventoira. HEINRICH KIXIII and GABRIEL PON GRAMZ
Address for ervice Spruscin Ferguson, Patent Attorneys, Esso House, 127 Kent Street, S, Inoy, New South Wales, Z000 Australia.
Complete Srecificatian far the invention cntltled N toI It OWUTTT.Q1OTC
The follcwing statement is a full description of this invention, including the best method of performing it known to ifb/us
RAN 4602/11
The present invention concerns emulsions of oils or fats consisting of glycerides of fatty acids with 8 to 22 carbon atoms or of a vitamin E-active substance and optionally water-soluble and/or fat-soluble additives and/or active
substances in aqueous sugar or sugar alcohol solutions, the
sugar or sugar alcohols containing 5 or 6 carbon atoms per monosaccharide, whichare characterised in that they contain
about 0.5 to 10 wt.% of a physiologically harmless
*emulsifier, the emulsified particles have an average size of l less than 100 mL, the ratio of the aqueous phase to the oil phase amounts to about 50-90 to about 10-50 wt.% and
the sugar or sugar alcohcl concentration in the aqueous
phase constitutes at least 50 wt.%.
The invention also concerns a process for the manufacture S 15 of such emulsions.
It is often necessary or desirable to administer
vitamins and also pharmacological active substances in the
form of aqueous solutions or in the form of syrups. In this case, however, the problem always arises insofar as fat- -soluble vitamins or active substances are concerned of the emulsifiers necessary for the manufacture of such preparations, the non-ionic emulsifiers, such as perhaps those under the
Trade Mark Tween 80, Cremophor EL and the like, finding the most widespread use. One advantage of these non-ionic emulsifiers lies esecially in their comoatability with
numerous active substances and adjuvants, which are normally used in the food or feedstuff sectors and, in
-2 Cot/2.11.1973 particular, in the pharmaceutical industry. There is, however, a tendency in most countries, not to use non-ionic emulsiers in foods. A greater disadvantage also lies in that, for example, the solutions manufactured using non-ionic emulsifiers are usable only for a short time or not at all since they are not disposed with the necessary physical stability if they contain polyols such as sugar syrup, invert sugar syrup, sorbitol syrup and the like in a relatively high concentration, in
10 particular, polyol concentrations of over about
A further, especially significant disadvantage of the
non-ionic emulsifiers also lies in that these substances
have a sometimes rather pronounced, unpleasant flavour and/or odour which can then also accompany the preparations 15 manufactured therewith.
There have also already been manufactured emulsions
with the aid of hydrocolloids buch as traganth, gum arabic, alginates, cellulose derivatives and the like. The stability of such emulsions is based here on the viscosity
increasing action of the hydrocolloid. The compatability with additives or active substances can, however, be slir:ht and the physical stability limited since they represent
usual emulsions. The particle size of the dispersed phase
lies in the p region, i.e. the bulk of the dispersed phase is
present in particle' with a diameter of over 1 i.
Lt has now been found that the emulsions in accordance
with the invention have none of the previously mentioned
disadvantages.
The process for the manufacture of the emulsions in
accordance with the invention, is characterised in that about 0.5-10 wt. of a physiologically harmless emulsifier, about 10-40 wt.% of an oil or fat consisting of glycerides of fatty acids with 8 to 22 carbon atoms or about 5-20 wt.% of a vitamin E-active substance and about 60-90 wt.% of an
S: 10 at least 50 wt.% aqueous sugar or sugar alcohol solution the sugar or sugar alcohols containing 5 or 6 carbon atoms per monosaccharide as well as, if desired, up to 5 wt.% water-soluble and/or up to 15 wt.% fat-soluble additives and/or active substances are mixed and the obtained emulsion
homogenised.
The emulsifiers coming into use in accordance with the
invention are physiologically harmless emulsifiers exceptionally admissable under the food laws and with an HLB value of at least 8. There can be named as examples thereof lecithin, especially the alcohol-soluble
fraction thereof, ascorbyl palmitate, Elulsifier YN of the firm Cadbury Ltd and the like. The concentration of the emulsifier can lie .n the range of about 0.5 to 10 wt.%, preferably however, in the range of about 3-5 with respect to the total weight of the emulsion.
The homogenising is expediently effected under pressure
using an ultrasonic turbine mixer or even using a high-speed turbine mixer.
If the homogenising is carried out under pressure,
tLis is expediently effected at a pressure of about 150-450
atm, preferably about 200-300 atm and especially at a
pressure of about 250-280 atm.
S* The homogenising is expediently effected at a
1. temperature between about room temperature and about 900 C, 10 preferably at a temperature of about 40-800C, especially at about
S The emulsions in accordance with the invention are oil- -in-water emulsions, which are clear or transparen, to
completely opaque in a thin layer, their internal phase having 15 a surprisingly high degree of dispersion. It has been found that the internal phase has colloidal dimensions with particle sizes of less than 100 mLp.
The emulsions in accordance with the invention also have an exceptionally large physical stability (for example no separation in a clear emulsion results after
centrifuging for 4 hours in a laboratory centrifuge at 6000 revolutions/minute and a diameter of 18 cm).
The previously mentioned appearance, that is the transparence of the emulsions in accordance with the invention is in the main dependent on the refractive indices of the two phases, that is the water and the oil phase.
For the manufacture of transparent emulsions, for
example using Sirupus simplex,the oil phase must have a
refractive index of about 1.44-1.46. Oils with such a
refractive index are, for example, glycerides of fatty acids
with about 8-12 carbon atoms such as perhaps coconut fat, Neobee M-5, Miglyol 812, Drew oil 1223 etc. When using
l: other oils, that is glycerides of longer chain fatty acids 9 such as perhaps arachis oil, sunflower oil etc or when using a vitamin E-active compound as the oil phase, the obtained
emulsions are from opalescently transparent to completely opaque with an unchanged particle size of the internal phase *15 and an unchanged physical stability. These emulsions can,
however, also be manufactured transparent using aqueous sugar or sugar alcohol solutions which have a higert'refractive index
than Sirupus simplex for example 70-80%o fructose
syrup, 50-80 maltitol syrup and the like.
The aqueous phase consists of at least 50 wt.% of sugar
or sugar alcohol solutions, the sugar or sugar alcohols containing 5 or 6 carbon atoms per monosaccharide. There
can,accordingly,be used aqueous solutions of, for example, saccharose, fructose, sorbitol, glucose and the like, saccharose being preferred. An especially preferred
aqueous solution is Sirupus simplex consisting of 64%
saccharose and 36% water which moreover also has an
antimicrobial action.
The aqueous phase is expediently used in an amount of
about 50-90 wt.% with respect to the total weight of the emulsion, preferably in an amount of about 70-80 wt.%.
The oil phase consists, as already previously
mentioned, of glycerides of fatty acids with 8 to 22 carbon
atoms or of a vitamin E-active substance. The amount of
the oil phase with respect to the total weight of the emulsion
amounts expediently to about 10-50 preferably about a o 10-30 and especially about 10-20 when using
10 glycerides of fatty acids. When using a vitamin E-active
substance as the oil phase, the amount with respect to the
total weight of the emulsion expediently amounts to about
S5-20 preferably about 8-15 wt.'o%and especially about S. 10 wt.%. ao.
15 There can be used as vitamin E-active substances, in
V.O the scope of the present invention, not only the d and the
d,l-a-tocopherol alone,but also all the analogues thereof such as the 6-tocopherol etc and their esters, for
example tocopherol acetate and the like.
The emulsions in accoriunce with the invention possess
excellent organoleptic properties and can be readily mixed
with not only water-soluble but also fat-soluble additives
and/or active substances. They differ from the previously
used products especially in that they are free from the usual
non-ionic emulsifiers (Tween 80, Cremophor EL and the like)
and in that they can accordingly, also be used for foods and
feedstuffs and not just as pharmaceutical products. The emulsions in accordance with the invention differ from the emulsions manufactured using hydrocolloids especially by their substantially improved physical stability.
There can be named as additives and/or active substances,
which are usable in the scope of the present invention, for example: arcma substa-ses, colouring materials, water-soluble and/or fat-soluble vitamins such as perhaps vitamin C, vitamins of the B complexe vitamin A, vitamin E as well as
possible derivatives thereof and the like, carotinoids, as
10 well as pharmaceutical active substances and also preservatives
such as benzoic acid and the like.
o The amount of additive or active substance is governed by requirement and by the solubility in one of the two phases.
Thus, for example, water-soluble additives or active substances 15 can be used optionally in an amount up to 5 wt.% and fat- S-soluble additives or active substances in an amount up to
o 15 wt.%. imo oe•
I Example 1
parts by weight of lecithin are dissolved in 200 parts by weight of coconut fat and mixed together with 770 parts by weight of Sirupus simplex. The emulsion is then
homogenised at 600C in a pressure homogeniser at 280 atm, a transparent emulsion being obtained.
This produces a milk-like liquid with water and can
serve for example with aroma substances as a fruit syrup. 0
Example 2
10 30 parts by weight of lecithin, 5 parts by weight of
o• 7-chloro-l,3-dihydro-l-methyl-5-phenyl-2H-l,4-benzodiazepin- S -2-one (Diazepam) and 2 parts by weight of lemon oil are
dissolved in 200 parts by weight of Neobee M-5 and made up
to 1 litre with Sirupus simplex. The emulsion is then 15 homogenised at 6000 in a pressure homogeniser at 280 atm, a stable, pleasant-tasting, transparent emulsion with 5 mg
of Diazepam/ml being obtained.
Example 3
18 parts by weight of vitamin A palmitate, 182 parts by weight of arachis oil and 30 parts by weight of lecithin
are mixed with 770 parts by weight of Sirupus simplex and
homogenised as in Example 1. There is obtained an
opalescent/transparent emulsion with 30,000 IUA/ml.
Example 4
100 parts by weight of tocopherol acetate, 200 parts by weight of Drew oil 1223 and 30 parts by weight of
Emulsifier YN (Cadbury Ltd.) are mixed together with 670
parts by weight of Sirupus simplex and homogenised as in Example 1. There is obtained a pleasant-tasting and stable
emulsion, trans arent in a thin layer,
Example
200 parts by weight of paraffin oil, 2 parts by weight
of orange oil and 30 parts by weight of lecithin are mixed together with 768 parts by weight of Sirupus simplex and homogenised as in Example 1. There is obtained a transparent, pleasant-tasting emulsion which is usable as a laxative.
In an analogous manner, using 50 parts by weight of lecithin, castor oil can ilso be used instead of paraffin oil.
Example 6
600 parts by weight of the emulsion manufactured
according to Example 1,are mixed with 400 parts by weight
of 50%0 ethanol. There is obtained a pleasant-tasting, slightly 'iscous, alcoholic drink which can be used as a
liqueur base. The product is distinguished by a high calorie content.
Example 7
200 parts by weight of Miglyol-812, 50 parts by weight
of lecithin and 30 parts by weight of panthenol are mixed together with 740 parts by weight of Sirupus simplex and
homogenised as in Example 1. There is obtained a transparent emulsion.
Example 8
30 g of lecithin (alcohol-soluble fraction) are dissolved in 200 g of Neobee M-5 and mixed with 770 g of a 60% maltitol syrup. The emulsion is homogenised with
the turbine "ULTRA-TURRAX No TN 45" at maximum revolutions (mark In so doing the temperature rises; when the
temperature has reached 8000 it is cooled with the turbine running and there is obtained a clear emulsion which can
serve, for example, as a base for a diabetic syrup.
Example 9
100 g of d,l-tocopherol acetate, 50 g of lecithin
(alcohol-soluble fraction) and 850 g of an 80% fructose
syrup are mixed. The mixture is homogenised as in
Example 8 and there is obtained a transparent emulsion which, after aromatisation with 50 mg of orange oil and 30 mg of
peppermint oil, is usable as a high-dosage vitamin E syrup.
JExt&'nle
100 g of d,l a-toczopherol acetate, 50 g of lecithin (alcohol-soluble fraction), 840.5 g of Sirupus simplex, 2 g of banana aroma and 2.5 g of benzoic acid are mixed. The mixture is homogenised as in Example 8 and there is obtained an emulsion which is usable as a high-dosage vitamin E syrup.
Claims (8)
1. Process for the manufacture of emulsions of oils or fats consisting of glycerides of fatty acids with 8 to
22 carbon atoms or of a vitamin E-active substance and
optionally water-soluble and/or fat-soluble additives and/or
5 active substances in aqueous sugar or sugar alcohol solutions,
•the sugar or sugar alcohols containing 5 or 6 carbon atoms
per monosaccharide, characterised in that about 0.5-10 wt.% 0*
of a physiologically harmless emulsifier, about 10-40 wt.%
of the oil or fat or about 5-20 wt.% of a vitamin E-active 10 substance and about 50-90 wt.% of an at least 50% aqueous
sugar or sugar alcohol solution as well as, if desired,
up to 5 wt.% of water-soluble and/or up to 15 wt.% of fat- '-soluble additives and/or active substances are admixed
and the obtained emulsion homogenised.
15
2. Process according to claim 1, characterised in that
the vitamin 6-active substance is used in an amout of
about 8-15 wt.% and preferably in an amount of about
wt.%.
3. Process according to claim 1 or 2, characterised in that d,l-a-tocopherol acetate is used as the vitamin
E-active substance.
4. Process according to any one of claimp 1 to 3,
characterised in that Sirupua simplex is used as the aqueous
sugar solution.
Emulsions of oils or fats consisting of glycerides
of fatty acids with 8 to 22 carbon atoms or of a vitamin E-
-active substance and optionally water-soluble and/or fat-
-soluble additives and/or active substances in aqueous sugar
or sugar alcohol solutions, the sugar or sugar alcohols
containing 5 or 6 carbon atoms per monosaccharide, which are characterised in that they contain about 0.
5 to 10 wt.% of
a physiologically harmless emulsifier, the emulsified
particles have an average size of less than 100 mI, the ratio
of the aqueous phase to the oil phase amounts to about 50-90
to about 10-50 wt.% and the sugar or sugar alcohol concen-
tration in the aqueous phase constitutes at least 50 wt.%.
6. Emulsions according to claim 5, characterised in
that they contain the vitamin E-active substance in an amount
of about 8-15 wt.% and preferably in an amount of about
wt.%.
7. Emulsions according to claim 5 or 6, characterised
in that they contain d,l-a-tocopherol acetate as the
vitamin E-active substance.
8. Emulsions according to any one of claims 5 to 7, characterised in that they contain Sirupus simplex as the aqueous sugar solution.
DATED this THIRTEENTH day of NOVEMBER, 1973
F. HOFFMANN-LA ROCHE CO. AK~TIENGESELLSCHAFT
Patent Attorneys for the Applicant SPRUSON FERGUSON
IN
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH9873 | 1973-01-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6253473A true AU6253473A (en) | 1975-05-15 |
Family
ID=4179198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU62534/73A Expired AU6253473A (en) | 1973-01-05 | 1973-11-15 | Emulsions |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS49101272A (en) |
| AU (1) | AU6253473A (en) |
| BE (1) | BE809387A (en) |
| DE (1) | DE2363534A1 (en) |
| FR (1) | FR2213023A1 (en) |
| HU (1) | HU167294B (en) |
| IL (1) | IL43629A0 (en) |
| NL (1) | NL7316276A (en) |
| ZA (1) | ZA738657B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2405068A1 (en) * | 1977-10-10 | 1979-05-04 | Sauba Lab | Water in oil emulsions for dry skin - contg. vitamin=A, stigmasterol, allantoin, and alpha tocopherol |
| GB2080106B (en) * | 1980-07-18 | 1984-03-07 | Weelcome Foundation Ltd | Acyclovin preparations |
| KR830005852A (en) * | 1980-07-18 | 1983-09-14 | 미첼 페터 잭슨 | Preparation of topical treatments suitable for the treatment of viral infections on skin and mucous membranes |
| JPS60153756A (en) * | 1984-01-25 | 1985-08-13 | Ajinomoto General Food Kk | Nonmilk creamer capable of retaining fluidity in freezing |
| FR2561916B1 (en) * | 1984-03-30 | 1987-12-11 | Lafon Labor | GALENIC FORM FOR ORAL ADMINISTRATION AND METHOD FOR PREPARING IT BY LYOPHILIZATION OF AN OIL-TO-WATER EMISSION |
| JPS63226244A (en) * | 1987-03-16 | 1988-09-20 | Wakoudou Kk | Synthetized milk |
| DE4200728A1 (en) * | 1992-01-14 | 1993-07-15 | Basf Ag | STABLE, LIQUID PREPARATIONS OF FAT-SOLUBLE SUBSTANCES |
| DE4405545A1 (en) * | 1994-02-22 | 1995-08-31 | Dietl Hans | Oral vitamin compsn. with improved resorption |
-
1973
- 1973-11-12 ZA ZA738657A patent/ZA738657B/en unknown
- 1973-11-14 IL IL43629A patent/IL43629A0/en unknown
- 1973-11-15 AU AU62534/73A patent/AU6253473A/en not_active Expired
- 1973-11-28 NL NL7316276A patent/NL7316276A/xx unknown
- 1973-12-10 JP JP48136942A patent/JPS49101272A/ja active Pending
- 1973-12-20 DE DE2363534A patent/DE2363534A1/en active Pending
-
1974
- 1974-01-04 BE BE139509A patent/BE809387A/en unknown
- 1974-01-04 FR FR7400244A patent/FR2213023A1/en active Granted
- 1974-01-04 HU HUHO1638A patent/HU167294B/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2213023B3 (en) | 1976-10-22 |
| DE2363534A1 (en) | 1974-07-11 |
| HU167294B (en) | 1975-09-27 |
| IL43629A0 (en) | 1974-03-14 |
| JPS49101272A (en) | 1974-09-25 |
| FR2213023A1 (en) | 1974-08-02 |
| BE809387A (en) | 1974-07-04 |
| NL7316276A (en) | 1974-07-09 |
| ZA738657B (en) | 1974-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS514464A (en) | Junkatsuyu no saiseihoho | |
| AU7352974A (en) | Amine emulsions | |
| JPS5133102A (en) | Sekitan no gasukahoho | |
| CS668876A2 (en) | Automaticke bezkolejove pozemni dopravni zarizeni | |
| JPS511558A (en) | Atsushukuhizumi no hikui shirokisanerasutomaa | |
| AU6820074A (en) | Azolyl-amidines | |
| AU6876974A (en) | Railbed | |
| AU7374074A (en) | Pha-methylene-d-homo-delta4- | |
| JPS5195985A (en) | Fukugodenkyokutai no seizoho | |
| AU7015174A (en) | Glucuronyl-glucosamino-glycan-sulphonates | |
| AU7373674A (en) | D-homo-steroids | |
| AU6998874A (en) | Amine emulsions | |
| ZA738657B (en) | Emulsions | |
| AU6566574A (en) | Photoelectrophoresis | |
| AU7137874A (en) | Phenolaldehydes | |
| AU6616174A (en) | Flag-stone | |
| AU7351374A (en) | Carbo-chlorination | |
| AU7162574A (en) | Emulsions | |
| AU7381574A (en) | 6-demethyl-6-deoxy-6-methylene-tetracyclines | |
| AU7322774A (en) | Oleoresin emulsions | |
| JPS5152867A (en) | yobihyojibanoyobi hizukehyojiban no kudosochi | |
| JPS5110895A (en) | Horikaaboneeto no seizohoho | |
| AU6797274A (en) | Dichlorothiazolylureas | |
| AU6598974A (en) | 6-amino-th-benzocyclohepten-7-ones | |
| JPS5137457A (en) | Sokohoisuto no itsusoboshisochi |